Dr Boby Mihaylova
|Tel||+44 (0)1865 289226|
Associate Professor and University Research Lecturer
- Health Economics Research Centre
Borislava (Boby) Mihaylova is a University Research Lecturer and a Senior Researcher in Health Economics at the Health Economics Research Centre at the University of Oxford. Her research programme focuses on economic aspects of chronic disease (such as cardiovascular, chronic kidney disease and diabetes) and comprises studies of the impact of disease events and interventions on morbidity, mortality, health-related quality of life and healthcare costs; development of disease models to evaluate long-term effects of disease and interventions, cost-effectiveness analyses of healthcare interventions and studies of socio-economic determinants of health. She is leading the development of the economic analyses in a number of large randomised controlled trials (SHARP, THRIVE, REVEAL and ACST-2) and in the individual participant data meta-analysis of statin trials (Cholesterol Treatment Collaboration). Her work on effectiveness and cost-effectiveness of statins for cardiovascular disease prevention in the Heart Protection Study and the Cholesterol Treatment Collaboration has been influential in informing treatment recommendations for people at different vascular disease risk.
A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.
Schlackow I. et al, (2017), Heart
Body mass index and healthcare costs: a systematic literature review of individual participant data studies.
Kent S. et al, (2017), Obes Rev, 18, 869 - 879
The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trials.
Clayton GL. et al, (2017), Trials, 18
Hospital costs in relation to body mass index in 1.1 million women in England: a prospective cohort study
Kent S. et al, (2017), Lancet Public Health
Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe.
Achelrod D. et al, (2017), Eur J Prev Cardiol, 24, 426 - 436